Introduction
============

The capsular tension ring (CTR) was first described in 1991 by [@b12-opth-1-65]. They named it an "equator ring", designed to maintain the circular contour of the capsular bag after lens removal during cataract surgery. However, their flexible silicon ring did not adapt to the different capsular bag sizes. In 1993, a different design was introduced allowing for an individual expansion and therefore being applicable for eyes with different dimensions ([@b17-opth-1-65]). Since then, the first polymethylmethacrylate (PMMA) open capsular ring was produced by Morcher^®^ (Stuttgart, Germany). Soon others (Ophtec^®^, Ioltech^®^, Acrimed^®^, etc.) began to produce similar devices. Nowadays, various designs have been developed for average individuals (Morcher^®^ type 14, 10.0 mm closed diameter), highly myopic patients (Morcher^®^ type 14A, 12.0 mm), and for children (Morcher^®^ type 1C, 9.00 mm). In addition special CTRs were designed for cases with severe zonular dehiscence and an additional fixation hook for scleral fixation ([@b3-opth-1-65], [@b4-opth-1-65]; [@b13-opth-1-65]; [@b1-opth-1-65]). Coloboma shield CTRs and multisegmental coloboma rings have been suggested for large sector iris defects or congenital aniridia. [@b19-opth-1-65], [@b18-opth-1-65]) recently developed a square edged CTR to prevent posterior capsule opacification ([@b5-opth-1-65]).

Originally the CTR was designed to stabilize the capsule in eyes with zonular weakness or dehiscence ([@b9-opth-1-65]; [@b22-opth-1-65]; [@b10-opth-1-65]), intraocular lens (IOL)-luxation ([@b11-opth-1-65]; [@b6-opth-1-65]), pseudoexfoliation syndrome ([@b16-opth-1-65]; [@b2-opth-1-65]), and highly myopic eyes not receiving a posterior chamber intraocular lens (PCIOL). In past years the CTR has been widely used throughout Europe, but this far was not FDA-approved in the USA. The purpose of our study was to evaluate the frequency, indications, and clinical outcome of CTR implantation in a large series of consecutive cataract surgical cases performed during the years 1997 through 2001 in our institution.

Patients and methods
====================

Surgical technique
------------------

After preoperative dilation of the pupil the conjunctival sac was flushed with 10 ml 10% povidone iodine rinsing solution. Superior, either a sclerocorneal or a clear corneal incision, was created using a diamond blade followed by a 2.75 mm steel keratome (Alcon, Fort Worth, TX). Further two 1.2 mm clear corneal incisions were performed with a 15° keratome (Alcon) and the anterior chamber was expanded with a viscoelastic substance (Healon, AMO, Santa Ana, CA). For cataract surgery of mature cataracts, Trypan blue (vision blue, DORC, Netherlands) was used to enhance visualization of the anterior lens capsule. Capsulotomy was performed using a 25 gauge needle. After hydrodissection cataract extraction was performed using the divide and conquer technique. The Megatron S3 (Geuder, Heidelberg, Germany) phacoemulsification unit was used, with an ultrasound power set 50% to 100% and a phaco tip angled at 30 degrees.

Chart review
------------

We retrospectively reviewed the cataract database of the Department of Ophthalmology, Ludwig-Maximilians-University, Munich for records indicating implantation of a CTR. Since the first documented implantation of a CTR in our institution, all subsequent records were screened for indication of a CTR implantation, and subsequently clinical outcome was analyzed. In all cases a CTR Morcher^®^, Type 14 (open diameter 12.3 mm, PMMA) was used ([Figure 1](#f1-opth-1-65){ref-type="fig"}). Specific indications included zonulolysis or posterior capsular rupture. In case of a zonulolysis, exogenous (trauma, prior pars-plana-vitrectomy with silicone oil tamponade), or endogenous (pseudoexfoliation syndrome, Marfan syndrome) causes were distinguished. The decision to insert the CTR was made intraoperatively when loose zonules where apparent during capsulorhexis or phacoemulsification, or when a posterior capsular rupture occurred. In case of a posterior capsular rupture, an anterior vitrectomy was performed. Our surgeons mainly used phacoemulsification to extract the cataract; a planned extracapsular cataract extraction was performed only twice. In all cases, the CTR was inserted with a special shooter. If accidental displacement into the vitreous occurred during the procedure, the CTR was removed.

The main clinical outcome measurement was a possible PCIOL-implantation with differentiation between implantation in the capsular bag or the ciliary sulcus. In addition, the position of the intraocular lens was noted. In case of IOL subluxation or dislocation, the clinical symptoms (eg, monocular double vision) were evaluated.

Results
=======

During the period of review of 5 years, 9528 cataract surgeries were performed in our department. In 69 of these surgeries (67 patients) a CTR was implanted ([Table 1](#t1-opth-1-65){ref-type="table"}). Among these patients 37 (55%) were male and 30 (45%) were female. The mean age was 62 years with a range from 22 to 101 years. The range of follow up was between one and three years.

The indications for CTR implantation were as follows: In 35 eyes, a zonular dehiscence or weakness of different origin was observed before surgery, with exogenous causes of zonulolysis being evident in 29 eyes (23 with prior trauma and 6 with history of pars plana vitrectomy and silicone oil tamponade) and endogenous zonulolysis being apparent in 6 eyes; specifically, 4 eyes (6%) with pseudoexfoliation syndrome and 2 eyes (3%) of one patient with Marfan syndrome. In 23 eyes, a zonular rupture occured during cataract surgery itself. In the remaining 11 eyes, no underlying predisposition could be identified before surgery. Most likely in these cases the zonulolysis occured during the procedure. An advanced or mature cataract was present in 40 eyes (58%).

All in all, implantation of a CTR was chosen because of zonular dialysis in 61 eyes (88%), rupture of the posterior capsule in one eye (2%), or both zonular dialysis and rupture of the posterior capsule in 7 eyes (10%).

In 67 eyes (98%), an implantation of a posterior chamber intraocular lens (PCIOL) was performed without complication following the implantation of a CTR. In 61 cases (90%), an implantation into the capsular bag could be accomplished, whereas in 5 eyes (7%), the PCIOL had to be implanted into the ciliary sulcus. In one eye (1%) no IOL implantation was performed because of high myopia.

Thus, in only two of 69 eyes (2%) an IOL implantation into the capsular bag or ciliary sulcus was not possible despite prior CTR insertion: In one eye IOL implantation into capsular bag or ciliary sulcus was not possible due to extensive zonulolysis. In the second case an implanted PCIOL and the CTR dislocated into the vitreous 5 days after surgery and had to be removed. Both of these eyes received an anterior chamber IOL.

The PCIOL remained in a centered position in 61 eyes (92%) whereas in 5 eyes (8%) a dislocation of the IOL was observed during slit lamp biomicroscopy. However none of these patients complained of any symptoms such as monocular diplopia and the decentration was stable and did not progress further during follow up.

Discussion
==========

The present study was performed to address two subjects: First, to evaluate the frequency of CTR implantation in a large consecutive series of cataract surgeries. Second, to investigate whether an anatomically reasonable outcome could be reached by the insertion of a CTR in a variety of complicated cataract surgeries. Final visual outcome was not investigated in our study as the group of patients investigated was rather heterogenous with a large spectrum of additional diseases such as macular degeneration and diabetic retinopathy that would have significantly biased any evaluation of functional outcome. Therefore, the present study aimed at an anatomical or morphological evaluation of the surgical results and focused on the applicability of CTR implantation during cataract surgery.

Since the first insertion of a CTR in our institution, 9528 cataract surgeries have been performed during the following period of 5 years. Despite the fact that predominantly severe forms of cataracts and complicated cases are relatively frequent in our tertiary care center university setting, only relatively few cases (0.7%) required the implantation of a CTR, probably because the surgeries were done by experienced anterior segment surgeons. The predominant indication for CTR implantation was determined by an unstable intraoperative condition either caused by zonular dehiscence or weakness and/or posterior capsular rupture, or by different conditions including mature cataract (40 eyes, 58%), traumatic cataract (23 eyes, 33%), pseudoexfoliation syndrome (4 eyes, 6%), and subluxated lenses due to Marfan syndrome (2 eyes, 3%). The indications for CTR implantation are in line with other authors who also used the CTR in eyes with intraoperative signs for loose or broken zonules like decentration of the crystalline lens, movement of the lens during capsulorhexis, phacoemulsification or irrigation/aspiration ([@b9-opth-1-65]; [@b22-opth-1-65]; [@b16-opth-1-65]; [@b14-opth-1-65], [@b15-opth-1-65]; [@b10-opth-1-65]). Like other authors ([@b16-opth-1-65]; [@b10-opth-1-65]), our surgeons inserted the CTR as soon as zonular weekness was seen intraoperatively, for example before or after hydrodissection and prior to phacoemulsification or after complete phacoemulsification and prior to PCIOL insertion.

The PCIOL was successfully implanted in almost all cases (97%), with an implantation in the capsular bag being possible in the majority of cases (91%). Only in two cases no permanent implantation of an PCIOL was possible despite prior insertion of a CTR; in one of these eyes a dislocation of both the CTR and the PCIOL occurred due to extended zonular dehiscence and led to explantation of both implants ([Table 1](#t1-opth-1-65){ref-type="table"}).

In our series one highly myopic eye was left without IOL. The CTR helps in these cases to maintain the circular contour of the capsular bag and the shape of the continuous circular capsulorhexis ([@b22-opth-1-65]). Thus, folds in the posterior capsular bag are minimized.

The only postoperative complication found in our series was minor PCIOL decentration noted biomicroscopically during follow up, but no subjective visual symptoms were noted by the patients. Because this was a retrospective chart review we were unable to determine whether the same results would have been reached without CTR implantation.

At the moment several clinical studies are also attempting to investigate if routine CTR insertion is reasonable to prevent capsular shrinkage and posterior capsule opacification ([@b20-opth-1-65]; [@b19-opth-1-65], [@b18-opth-1-65]; [@b5-opth-1-65]; [@b7-opth-1-65]; [@b21-opth-1-65]; [@b23-opth-1-65]). Since the invention of the capsular tension ring in 1991, many authors have reported its advantages in anterior segment surgery. Our results in this large series over a relatively long period of time confirm that CTR implantation is a useful device for cataract surgery in selected cases with difficult pre- or intraoperative conditions ([Figure 2](#f2-opth-1-65){ref-type="fig"}).

A weakness of the present study is the retrospective nature and the lack of a control group. Obviously, only a prospective randomized study could further elucidate whether the same clincial outcome (eg, possibility of PCIOL implantation) could be achieved without prior implantation of a CTR. However, the following aspects should be considered in this context: First, based on our study with a frequency of CTR implantation of 0.7%, the number of cataract cases included will have to be very large to achieve statistical power. Second, the decision whether to implant a CTR or not is usually made during surgery; this approach interferes with a prospective randomized study setting. Third, patients would have to give their informed consent prior to surgery allowing for the randomized (non-) use of a CTR even in the event of complicated surgery. In the absence of such a randomized study to the best of our knowledge our experience represents the largest series of consecutive cataract surgeries that was evaluated for implantation of a CTR.
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![Morcher^®^ type 14 CTR (open diameter 12.5 mm)(down) and IOL (up).\
**Abbreviations:** CTR, capsular tension ring, IOL, intraocular lens.](opth-1-65f1){#f1-opth-1-65}

![UBM findings after CTR and IOL insertion (intraoperative zonulolysis over 4 clock hours) ([@b8-opth-1-65]).\
**Notes:** CTR (1), haptic of IOL (2), and IOL (3).\
**Abbreviations:** CTR, capsular tension ring, IOL, intraocular lens; UBM, ultrasound biomicroscopy.](opth-1-65f2){#f2-opth-1-65}

###### 

Patients with CTR implantation: pre- and post-operative characteristics

  **Pre-op characteristics**   **Post-op characteristics**                                                                   
  ---------------------------- ----------------------------- -------------------- --------------------------- -------------- ----
  Mean age                                                   62                   CTR and IOL                 Capsular bag   61
  Sex                          Male                          37                   Sulcus                      5              
  Female                       30                                                                                            
  Diagnosis                    Mature cataract               40                   CTR only (no IOL planned)                  1
  Traumatic cataract           23                                                                                            
  Subluxated lens              2                             No IOL despite CTR                               2              
  PEX                          4                                                                                             

**Abbreviations:** CTR, capsular tension ring, IOL, intraocular lens; PEX, pseudoexfoliation syndrome.
